The clinical course was technically straightforward. The woman, who had obesity and obstructive sleep apnea, arrived with dyspnea and tense ascites. Her MELD-Na score of 27 and Child-Pugh C status marked her as having decompensated cirrhosis with a prognosis measured in months, and she was not a liver transplant candidate. Her hospital stay was complicated by hepatic encephalopathy, which resolved with lactulose and rifaximin, followed by hypercapnic respiratory failure with a pH of 7.1 and pCO2 of 70 mmHg. She improved on BiPAP but could not tolerate the mask. A goals-of-care conference documented DNR/DNI status and comfort measures only. Over the following week, her creatinine rose from 1.6 to 4.4 mg/dL, consistent with acute kidney injury on cirrhosis, driven by massive ascites and persistent hypotension. She remained relatively asymptomatic. The medicine was appropriate. The system around it was not.

The barrier emerged at the moment of discharge. The woman was widowed; her only family were elderly siblings. Her sister was housebound due to her own medical conditions, and her brother, who held her power of attorney, was caring for an ill partner a thousand miles away. Around-the-clock home care was impossible. She required nursing facility placement with hospice—but the Medicare hospice benefit, established in 1982, does not cover room and board in a nursing facility. She had no savings. A Medicaid application was submitted, but approval remained pending. One nursing home demanded two months of room and board payment upfront: $18,000. Some facilities nationally do accept Medicaid-pending patients, absorbing short-term financial risk with the expectation of retroactive reimbursement. The facilities in her area did not. After four days without urine output, a skilled nursing facility finally accepted her into a subacute bed under Medicare billing. She was transferred and died shortly thereafter. The coverage gap was bridged not by policy but by clinical deterioration severe enough to qualify for an alternative billing pathway.

The authors are careful about the policy conditions surrounding the case. It occurred in a Medicaid expansion state, at a safety-net hospital, in an urban center with multiple hospice agencies. On paper, the woman qualified for both Medicare and Medicaid. Federal law allows 45 days for Medicaid eligibility determination, though average processing time frequently approaches 90 days. Her prognosis was days to weeks. The gap between eligibility and approval exceeded her survival. The medical team could not execute her wishes. The hospital could not discharge her while she was present and aware. The barrier was not clinical judgment or individual failure, the authors write. It was structural—a policy gap between program eligibility and program access.

The ethical analysis cuts across all four foundational principles of medical ethics. Autonomy was compromised: she had decisional capacity, documented goals of care, and family agreement, but her choice could not be delivered. Beneficence was compromised in a form the authors identify as moral distress—knowing the right course and being prevented from taking it, a condition shared by the medical team, the hospice agencies, and the hospital alike. Non-maleficence was compromised environmentally: the harm of overhead pages and beeping monitors was caused not by anyone’s action but by the absence of an alternative. And justice was compromised in the starkest terms. The same patient enrolled in VA care would have received a different death, because the VA hospice benefit covers room and board in VA Community Living Centers and contracted community nursing homes with no upfront payment required. The death experience differed solely based on which system one enrolled in and who one is.

The case is not isolated, and the literature the authors review documents a pattern of structural barriers across populations and disease categories. A 2023 study of Medicaid-only and dual-eligible decedents found that Hispanic and non-Hispanic Black individuals had the lowest odds of receiving hospice care compared to non-Hispanic White individuals, with Hispanic decedents also having the highest odds of short hospice stays. Research shows hospice patients with lower incomes are significantly more likely to die in hospitals rather than at home, with the association strongest among patients requiring facility-based care. Hospice is particularly underutilized in decompensated cirrhosis: the AASLD Practice Guidance on Palliative Care reports that only 11% of these patients receive specialty palliative care or hospice referrals, often very late in the disease course, even though patients with MELD-Na above 21 or Child-Pugh score of 12 or higher have an estimated survival of six months or less and are prognostically appropriate. Even under universal healthcare, greater social deprivation independently predicted lower end-of-life care quality ratings among patients with liver disease—suggesting structural disadvantage shapes outcomes beyond insurance coverage alone.

What the literature does not document, the authors note, is the mechanism—the specific procedural sequence by which a patient who qualifies for both Medicare and Medicaid is nonetheless unable to access chosen end-of-life care in a chosen environment. Published case reports examining the Medicare-Medicaid coverage gap as a barrier to hospice access are absent. The temporal mismatch between Medicaid processing timelines and terminal prognosis has not been previously described in clinical case literature. This case fills that gap, and in doing so exposes a deeper demographic mismatch. The Medicare hospice benefit was built on the assumption that dying patients will be cared for at home by family. In 1982, when 11% of the US population was 65 or older and life expectancy at age 65 was 16.8 years, that assumption reflected demographic reality. It does not reflect our times.

The numbers tell the story of a society that dismantled its communal safety-net without rebuilding the policy infrastructure to replace it. Today 17% of the US population is 65 or older, and 28% of adults 65 and older—16.2 million people—live alone; among women 75 and older, 43% live alone. Among those who do have caregivers, 17% are themselves 65 or older, and 53% of those caregivers have two or more chronic diseases. Roughly one in three older adults lives at or below 200% of the federal poverty level, and one in five adults over 50 has no retirement savings. Among Medicare beneficiaries, 25%—approximately 15 million people—have incomes below the federal poverty level. While 71% of Americans prefer to die at home, only 30% achieve this goal. The benefit fails in both directions: even patients who can be discharged home receive inadequate custodial care support, with less than two hours of aide services per week under routine hospice and a per diem reimbursement that cannot cover basic caregiving needs, as documented by Knight and colleagues. For patients like this woman—widowed, childless, with elderly siblings caring for their own ill partners—the question of family willingness is irrelevant. Family capacity does not exist.

The authors offer practical and policy implications. For clinicians, the case highlights the importance of anticipatory Medicaid application for patients with terminal conditions: primary care physicians and gastroenterologists seeing patients with Child-Pugh C cirrhosis who are not transplant candidates should consider initiating Medicaid applications early, before decompensation and hospitalization, because the trajectory is known and processing times approaching 90 days require anticipation. For policy, expedited Medicaid determination for patients with terminal diagnoses would close the temporal gap this case documents—a procedural fix within existing federal programs, not a structural overhaul. Expedited pathways already exist in some states for medical emergencies. Social Model Hospice Homes, community-supported residential facilities providing around-the-clock care outside Medicare and Medicaid billing structures, represent an emerging alternative that sidesteps the coverage gap, though their reach is limited to the communities that sustain them—a local solution to a national problem.

The deeper fix, the authors conclude, requires confronting what the health system owes its members. Medicare policy should reflect today’s demographics, not the family structure of 1982. The counterargument—that Medicare is health insurance, not housing assistance, and room and board are living expenses outside the scope of any health system obligation—minimizes the bigger issue. The question is not whether Medicare should pay rent. The question is whether a patient has the right to die in a peaceful environment, and whether the health system has an obligation to make that possible. Dignity at end of life is not a luxury. It is the last expression of autonomy a person has. Working Americans who contribute to Medicare throughout their careers are owed that. This case, the authors write, demonstrates the scar—and the suffering was not the patient’s alone.

Subject of Research: End-of-life care policy and the Medicare-Medicaid coverage gap

Article Title: The Last Expression of Autonomy: A Case of Ethical Failure in End-of-Life Care

Article References: Lee, T. C., Ghosh, S., & Braund, V. L. (2026). The Last Expression of Autonomy: A Case of Ethical Failure in End-of-Life Care. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10774-z

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10774-z

Keywords: end-of-life care, hospice access, Medicare hospice benefit, Medicaid coverage gap, medical ethics, palliative care, cirrhosis, health policy, moral distress, autonomy, Last, Expression